You are here

Cannabis and U.S. Financial Services: Regulation, Politics, and Normalization

Cannabis and U.S. Financial Services: Regulation, Politics, and Normalization

Though it exhibits volatility in its nascency, the cannabis industry has become a legitimate and material investment channel.

Boston, October 9, 2019 – Less than five years ago, cannabis was still a cause in search of funding, and typical investors were small. But since then this investment community has expanded to include single-family offices, institutions, asset management firms, and significant corporate entities. And many global consumer goods companies now have departments or designated professionals evaluating the cannabis sector. Given the industry’s current scale and high growth estimates, financial institutions and advisors should take notice.

This report, the first of two reports addressing how the cannabis industry will impact financial institutions and the wealth management business, covers aspects of the regulatory environment, politics, taxes, jobs, and broad industry normalization. The analysis in this report leverages interviews with U.S. industry incumbents conducted in the third quarter of 2019, and it is supplemented by secondary research.

This 46-page Impact Report contains 20 figures and seven tables. Clients of Aite Group’s Wealth Management service can download this report, the corresponding charts, and the Executive Impact Deck.

Download table of contents

This report mentions Ackrell Capital, Acreage Holdings, Akerman LLP, Altria Group, Arcview Group, BlackRock, BDS Analytics, Canopy Growth, Citrin Cooperman, Coca Cola, CohnReznick, Constellation Brands, Cronos Group, Davis Wright Tremaine, DavisPolk, Dorsey & Whitney, Duane Morris, EisnerAmpner, Fox Rothschild, Gallup, Goodwin Procter, Google, Green Growth Brands, Greenspoon Marder, Havas, iAnthus Holdings, indeed, Information Resources Inc., Innovative Industrial Properties, Johnson & Johnson, JPMorgan Chase, Kellogg’s, Khiron Life Sciences, Leafly, Manatt, Phelps & Phillips, Marcum LLP, Mastercard Advisors, McCarter & English, MedMen Enterprises, Molson Coors, New Frontier Data, Nielsen, Northern Swan Holdings, PKF O’Connor Davies, ScottsMiracle-Gro, Sheppard, Mullin, Richter & Hampton, Surterra Wellness, Tikun Olam, Vanguard, Vireo Health, Walgreens, Wilson Elser Moskowitz Edelman & Dicker, and Young & Rubicam Group.